blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4247421

EP4247421 - DESIGN OF OPTIMIZED UNIVERSAL INFLUENZA VACCINES, THEIR DESIGNS AND USES [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  25.08.2023
Database last updated on 03.10.2024
FormerThe international publication has been made
Status updated on  27.05.2022
Most recent event   Tooltip26.01.2024Amendment by applicant 
Applicant(s)For all designated states
Greffex, Inc.
1502 Augusta Dr., Suite 120
Houston, TX 77057 / US
[2023/39]
Inventor(s)01 / STAERZ, Uwe, D.
Denver, CO 80207 / US
02 / SPEAR, Philip, C.
Aurora, CO 80017 / US
03 / QI, Yan
Lone Tree, CO 80213 / US
04 / CULL, Janae, Wheeler
Brighton, CO 80603 / US
 [2023/39]
Representative(s)Zimmermann & Partner Patentanwälte mbB
Postfach 330 920
80069 München / DE
[2023/39]
Application number, filing date21895596.118.11.2021
[2023/39]
WO2021US59915
Priority number, dateUS202063115459P18.11.2020         Original published format: US 202063115459 P
[2023/39]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022109152
Date:27.05.2022
Language:EN
[2022/21]
Type: A1 Application with search report 
No.:EP4247421
Date:27.09.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 27.05.2022 takes the place of the publication of the European patent application.
[2023/39]
Search report(s)International search report - published on:KR27.05.2022
ClassificationIPC:A61K39/145, A61P31/16, C07K14/005, C12N15/86, A61K39/00
[2023/39]
CPC:
C07K14/005 (EP,KR); A61K39/145 (KR,US); A61K39/12 (EP);
A61P31/16 (EP,KR,US); G16B25/00 (KR); C12N2710/10343 (EP);
C12N2760/16122 (EP,KR); C12N2760/16134 (EP,KR) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/39]
TitleGerman:ENTWURF OPTIMIERTER UNIVERSELLER INFLUENZAIMPFSTOFFE, DEREN DESIGNS UND VERWENDUNGEN[2023/39]
English:DESIGN OF OPTIMIZED UNIVERSAL INFLUENZA VACCINES, THEIR DESIGNS AND USES[2023/39]
French:CONCEPTION DE VACCINS UNIVERSELS OPTIMISÉS CONTRE LA GRIPPE, LEURS CONCEPTIONS ET LEURS UTILISATIONS[2023/39]
Entry into regional phase14.06.2023National basic fee paid 
14.06.2023Search fee paid 
14.06.2023Designation fee(s) paid 
14.06.2023Examination fee paid 
Examination procedure14.06.2023Examination requested  [2023/39]
25.01.2024Amendment by applicant (claims and/or description)
Fees paidRenewal fee
14.11.2023Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]US2013052223  (MOOKAN PRABAKARAN [SG], et al);
 [A]US2016151480  (ZENG MINGTAO [US], et al);
 [A]US2019022209  (JONES FRANK R [US], et al);
 [A]US2019365882  (SEONG BAIK LIN [KR], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.